Miniature hearts used to test potential new drugs
10 April, 2019Australian scientists have conducted what is claimed to be the first ever screening of potential heart regeneration drugs using bioengineered human heart muscle.
Anti-TB drugs can actually increase risk of TB reinfection
05 April, 2019Anti-TB drugs cause changes to gut microbiota, increasing susceptibility to Mycobacterium tuberculosis infection as a result.
Potential male birth control pill passes human safety tests
03 April, 2019US scientists have announced promising results from their recent trial of an experimental male oral contraceptive.
'Antibiotic envelope' cuts infection risk from cardiac devices
27 March, 2019Encasing implantable cardiac devices such as pacemakers in a mesh sleeve embedded with antibiotics reduces the risk of major infection by 40%.
Pharmaceutical manufacturing and obsolescence management
19 March, 2019For many pharmaceutical manufacturing processes, often very old equipment or technology is still being used.
3D bioprinter Koligo Therapeutics to list on ASX
18 March, 2019Koligo Therapeutics, a regenerative medicine and 3D bioprinting company, will list on the Australian Securities Exchange at the end of March via an initial public offering.
New drug developed to treat heart attack damage
15 March, 2019UK researchers are working to develop drugs that could be given in the first few hours following a heart attack to minimise heart muscle death caused by the stress signals.
Fungus-based peptide found to kill TB bacteria
11 March, 2019Researchers have discovered a potential new pharmaceutical candidate for tuberculosis, finding that the antimicrobial peptide NZX rapidly and effectively kills TB bacteria.
Horse sperm can now be stored unfrozen for longer
08 March, 2019Scientists have developed a nutrient-rich liquid that enables collected horse semen to live for two weeks outside the body without the need to be frozen.
Positive trial results for peanut allergy therapy
01 March, 2019Trial data showed that Melbourne biotech company Aravax's therapy has a highly favourable safety profile, even in patients with severe peanut allergies.
Antivirals cut liver cancer risk in Hep C patients
28 February, 2019Direct-acting antivirals have been found to be associated with a reduced risk of liver cancer and death in people with chronic hepatitis C.
RecA protein and DNA-damage response
07 February, 2019Researchers have used molecular 'Velcro' to understand how an important protein, RecA, goes about repairing damaged DNA in bacteria.
Statin therapy found safe and effective in over 75s
06 February, 2019Statin therapy is safe and effective in older people over 75 years and reduces major vascular events such as heart attacks and strokes, according to new research.
Standard antibiotics courses may be too long
01 February, 2019Australian researchers are claiming that shorter courses of antibiotics are nearly always as effective as longer ones for many common infections.
Virus engineered to target and kill cancer cells
30 January, 2019Scientists have engineered a virus that selectively targets and kills cancer cells, with a stronger anticancer effect than another engineered virus currently used in clinical practice.
